Given our observations, it will be interesting to ask if human mutations in mfn1 or mfn2 that decrease their abilities to be targeted for ubiquitin-dependent degradation, or mutations in MUL1, result in susceptibility for PD. The gene discussed is MFN2; the disease is Parkinson disease.